CME Group Remains a Top Investment for Waverton

Waverton Investment Management boosts stake in financial services provider

Mar. 2, 2026 at 4:07pm

Waverton Investment Management Ltd increased its stake in CME Group Inc. (NASDAQ:CME) by 9.0% during the third quarter, according to a recent 13F filing with the Securities and Exchange Commission. The institutional investor now owns 1,155,894 shares of the financial services provider's stock, making CME Group its 10th largest holding and accounting for approximately 4.0% of Waverton's portfolio.

Why it matters

CME Group is one of the world's largest derivatives exchanges, operating platforms for trading futures and options contracts across a range of asset classes. As a major financial services provider, CME Group's performance is closely watched by investors and analysts as an indicator of broader market trends and investor sentiment.

The details

Waverton Investment Management's increased stake in CME Group suggests the firm sees continued growth potential in the exchange operator. CME Group has benefited from rising interest rates and increased market volatility, which have driven trading volumes higher across its platforms.

  • Waverton Investment Management boosted its stake in CME Group during the third quarter of 2025.

The players

Waverton Investment Management Ltd

A UK-based investment management firm that oversees approximately $30 billion in assets.

CME Group Inc.

A global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX.

Got photos? Submit your photos here. ›

What they’re saying

“Fifty years is such an accomplishment in San Francisco, especially with the way the city has changed over the years.”

— Gordon Edgar, grocery employee (Instagram)

The takeaway

Waverton's increased stake in CME Group underscores the exchange operator's continued appeal to institutional investors amid volatile market conditions. As a major player in the global derivatives market, CME Group's performance will remain a closely watched indicator of broader financial trends.